Streetbeat News

Stock Prices

SNY

Sanofi (NASDAQ:SNY) is set to release its quarterly earnings report on 2023-07-28, with analysts estimating an EPS of $1.58. The company's past performance shows a correlation between EPS and share price. Last quarter, Sanofi missed EPS by $0.71, resulting in a 4.35% drop in share price. The company's shares are currently trading at $53.51, up 8.0% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

July 27, 2023 | 2:01 pm

AZN

AstraZeneca (NASDAQ:AZN) is set to release its quarterly earnings report on 2023-07-28, with analysts estimating an EPS of $0.95. The company's past performance shows a mixed trend of beating and missing EPS estimates, which has led to varied stock price changes. As of July 26, AstraZeneca's shares were trading at $69.38, up 4.11% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

July 27, 2023 | 2:01 pm

CME

Over the past 3 months, 6 analysts have published their opinion on CME Gr (NASDAQ:CME) stock. The analysts have an average price target of $201.17 versus the current price of CME Gr at $199.7, implying an upside. The current average has increased by 6.86% from the previous average price target of $188.25.

Portfolio Pulse from Benzinga Insights

July 27, 2023 | 2:00 pm

MCHP

Microchip Technology (NASDAQ:MCHP) has outperformed the market over the past 15 years, producing an average annual return of 12.48%. If an investor had bought $100 of MCHP stock 15 years ago, it would be worth $576.70 today.

Portfolio Pulse from Benzinga Insights

July 27, 2023 | 2:00 pm

CNQ

Canadian Natural Res (NYSE:CNQ) has outperformed the market over the past 20 years by 5.28% on an annualized basis, producing an average annual return of 13.4%. If an investor had bought $100 of CNQ stock 20 years ago, it would be worth $1,271.74 today.

Portfolio Pulse from Benzinga Insights

July 27, 2023 | 2:00 pm

AMED

Over the past 3 months, 11 analysts have published their opinion on Amedisys (NASDAQ:AMED) stock. According to these analysts, Amedisys has an average price target of $98.82, a decrease of 1.74% from the previous average price target of $100.57. The majority of the analysts are indifferent about the stock with 9 out of 11 giving a neutral rating.

Portfolio Pulse from Benzinga Insights

July 27, 2023 | 2:00 pm

SPY

The Pending Home Sales for June increased by 0.3%, which is lower than the estimated 0.5%.

Portfolio Pulse from Bill Haddad

July 27, 2023 | 2:00 pm

AAPL

MSFT

NVDA

QQQ

SPY

TSLA

The Market Clubhouse Morning Memo discusses trade strategies for SPY, QQQ, AAPL, MSFT, TSLA, and NVDA. The analysis is based on a proprietary formula that considers price, volume, and options flow. The memo provides bullish and bearish targets for each asset and recommends traders to monitor these stocks closely and adjust their tactics based on the market's pulse.

Portfolio Pulse from RIPS

July 27, 2023 | 1:59 pm

URGN

UroGen Pharma Ltd. has announced a private placement of 12,579,156 shares at $9.54 per share, raising $120 million in capital.

Portfolio Pulse from Benzinga Newsdesk

July 27, 2023 | 1:57 pm

AAPL

META

SNAP

Meta Platforms reported double-digit revenue growth for Q4 2021 and better than expected Q3 guidance, causing its stock to rise 7% in extended trading. The company's net income rose to $7.79 billion, with earnings per share of $2.98, exceeding Refinitiv's expectations. However, the Reality Labs unit is still struggling, posting a loss of $3.7 billion. Meta's CEO, Mark Zuckerberg, has initiated cost-saving efforts, including 21,000 job cuts.

Portfolio Pulse from Upwallstreet

July 27, 2023 | 1:48 pm